Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,079.7
-

 

  • STI Straits Times Index
    3,079.7
    -
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.5
    0.9 (0.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,194.1
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,517.6
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,062.7
    237.9 (0.85%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,833.9
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,573.3M
  • Value: 1,571.9M
  • Rise: 263
  • Fall: 92
  • Unch: 417

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Keppel DC Reit2.610-
3Cnergy0.013-
8Telecom0.069-
A-Smart0.200-
A-Sonic Aero^0.630-
ABF SG BOND ETF1.185-
ABR0.500-
ACH ADR US$15.000-
AEI^1.350-
AEM3.430-

World Indices

World Indices
Name Last Change
Nasdaq 13,379.0 -50.9
HSI 28,194.1
HSCEI 10,503.8
Jakarta 5,833.9
Nikkei 225 28,187.8 +363.0
SSE Comp 3,517.6
Shanghai A 3,687.1
Shanghai B 251.2
KOSPI 3,157.4 +22.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LARIMAR THERAPEUTICS INC LARIMAR THERAPEUTICS
Updated on 14 May 2021 (End of trading day)
Last (USD): 13.370 Change: +1.610 High: 13.652 Remarks: -
Change (%): +13.69 Low: 11.560
Open 11.620 Yesterday's Close 11.76
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 221,358 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.76437 Trailing EPS (USD) e -3.11660 NAV (USD) b 5.1266
PE a - Trailing PE f - Price / NAV b 2.6080
Dividend (USD) d - Cash In Hand (USD) g 4.0470 Issued & Paid-up Shares c 15,367,700
Dividend Yield (%) d - Price / Cash In Hand g 3.304 Treasury Shares h -
Market Cap (M) 205.466 Enterprise Value (M) 130.422
Piotroski F Score 2 Exchange Code LRMR Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 96.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 May 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LARIMAR THERAPEUTICS INC NASDAQ 205.466 - - 2.6080 -
Industry Biotechnology NASDAQ 2,866.710 106.306 106.381 6.3446 0.614
Local Peer AMGEN INC NASDAQ 144,431.385 19.883 20.386 15.4737 2.563
Local Peer GILEAD SCIENCES INC NASDAQ 85,948.955 698.787 285.545 4.5351 3.968
Local Peer MODERNA INC NASDAQ 64,798.589 - 108.329 16.8834 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,197.220 20.724 20.346 6.2579 -
Local Peer ILLUMINA INC NASDAQ 55,630.380 84.802 88.302 11.3024 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,042.746 15.667 13.748 4.5957 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 46,558.003 2,687.439 32.032 15.7222 -
Local Peer BIOGEN INC NASDAQ 42,187.017 10.545 14.008 3.9493 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 38,344.586 63.548 56.240 3.0881 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 29,339.111 - - 7.3280 -
Local Peer SEAGEN INC NASDAQ 26,767.857 43.619 40.517 7.8163 -
Local Peer INCYTE CORPORATION NASDAQ 18,170.038 - 37.974 6.6610 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), INSMED INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), XENCOR INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), INSTIL BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SEER INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OCUGEN INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ALLOVIR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), IMMUNOVANT INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OMEROS CORP (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MIMEDX GROUP INC (NASDAQ), HUMANIGEN INC (NASDAQ), AFFIMED N V (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VAXCYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), EPIZYME INC (NASDAQ), NKARTA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), PASSAGE BIO INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VAXART INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHEMOCENTRYX INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), AGENUS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), IMMATICS N V (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), COMPUGEN (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), INHIBRX INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), ALTIMMUNE INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), GERON CORP (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), ATRECA INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), IMMUNOME INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SAVARA INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), IMV INC (NASDAQ), EQUILLIUM INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), EVOGENE LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ORGENESIS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), OTONOMY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), ARAVIVE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), METACRINE INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOCARDIA INC (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PALISADE BIO INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 125,872.538 40.134 33.074 11.9115 1.061
Global Peer WUXI BIO HKEx 449,596.349 236.903 236.905 18.4397 -
Global Peer BEIGENE HKEx 230,318.480 - - 7.3996 -
Global Peer SINO BIOPHARM HKEx 158,323.994 50.844 50.845 7.9739 0.870
Global Peer ZAI LAB-SB HKEx 113,621.640 - - - -
Global Peer GENSCRIPT BIO HKEx 47,589.266 - - 6.8065 -
Global Peer JOINN HKEx 38,402.361 108.488 85.066 4.9079 0.232
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer KINTOR PHARMA-B HKEx 24,990.226 - - 13.9778 -
Other Global Peers 3SBIO (HKEx), NUVATION BIO INC (NYSE), ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), MYOVANT SCIENCES LTD (NYSE), JACOBIO-B (HKEx), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), ASCENTAGE-B (HKEx), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), IMUGENE LIMITED (ASX), JHBP-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), ASCLETIS-B (HKEx), ANTEOTECH LIMITED (ASX), SINOMAB BIO-B (HKEx), 22ND CENTURY GROUP INC (NYSE American), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), NANOVIRICIDES INC (NYSE American), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), ENZO BIOCHEM INC (NYSE), BIOMX INC (NYSE American), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), UNI-BIO GROUP (HKEx), ACTINOGEN MEDICAL LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx), GENETIC TECHNOLOGIES (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), MEMPHASYS LTD (ASX), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BIOSINO BIO-TEC (HKEx), REGENEUS LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.250
+1.91 %
10 Days --0.490
-3.54 %
20 Days -+3.480
+35.19 %
Medium Term Return 3 Months --6.090
-31.29 %
6 Months --9.190
-40.74 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.000 - 25.870 Change From 1 Year Low +5.370 % Change From 1 Year Low (%) +67.12
Change From 1 Year High -12.500 % Change From 1 Year High (%) -48.32
2 Years Range 8.000 - 25.870 Change From 2 Years Low +5.370 % Change From 2 Years Low (%) +67.12
Change From 2 Years High -12.500 % Change From 2 Years High (%) -48.32
5 Years Range 8.000 - 25.870 Change From 5 Years Low +5.370 % Change From 5 Years Low (%) +67.12
Change From 5 Years High -12.500 % Change From 5 Years High (%) -48.32
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
14 May 2021 11.620 13.652 11.560 13.370 221,358 -
13 May 2021 10.210 12.000 10.210 11.760 423,072 -
12 May 2021 8.440 11.230 8.000 10.340 1,441,351 -
11 May 2021 11.250 11.800 8.360 8.360 618,310 -
10 May 2021 13.211 13.610 13.120 13.120